Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024
06 Febrero 2024 - 3:05PM
UK Regulatory
Monthly information related to total number of voting rights and
shares composing the share capital - January 31, 2024
Article 223-16 of general regulation
of French Autorité des Marchés Financiers
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code:
FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com
|
Date |
Total of shares composing the share capital |
Total of brut (1)
voting rights |
Total of net
(2)
voting rights
|
|
December 31, 2023 |
6 075 105 |
6 226 982 |
6 226 733 |
|
January 31, 2024 |
6 075 105 |
6 227 002 |
6 226 753 |
(1) Gross voting
rights number (or « theoretical » voting rights) is used
as a basis for calculating the crossing of the threshold. In
accordance with article 223-11 of general regulation of
Autorité des Marchés Financiers,
this number is calculated on the basis of
all shares carrying the single and double voting rights,
including shares without voting rights.
(2) Without treasury
shares.
- CP_Déclaration Droits de Vote 31 01 2024_vENG
Phaxiam Therapeutics (LSE:0QSS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Phaxiam Therapeutics (LSE:0QSS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
